Department of Pharmaceutics, School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai 201003, PR China.
Int J Pharm. 2011 Oct 31;419(1-2):260-5. doi: 10.1016/j.ijpharm.2011.07.019. Epub 2011 Jul 23.
Wheat germ agglutinin (WGA)-grafted lipid nanoparticles has been prepared and its in vitro association with Caco-2 cells has been studied previously. The purpose of this study was to further investigate the potential of WGA-grafted lipid nanoparticles for oral delivery of bufalin, a poorly water soluble drug, by evaluating its ex vivo bioadhesion with intestinal mucosal segments and in vivo bioavailability. A significant higher adhesion between WGA-grafted lipid nanoparticles and intestinal mucosa was found compared with that of WGA-free lipid nanoparticles (p<0.05). The in vivo pharmacodynamic studies were performed by oral administration of WGA-grafted lipid nanoparticles and suspensions to fasted rats. Compared with suspensions, WGA-grafted lipid nanoparticles showed much larger AUC and C(max), and a 2.7-fold improvement in oral bioavailability. These results illustrate the potential utility of WGA-grafted lipid nanoparticles for oral delivery of a poorly water-soluble drug such as bufalin.
小麦胚芽凝集素(WGA)接枝脂质体已被制备,并对其与 Caco-2 细胞的体外结合进行了研究。本研究的目的是通过评估其与肠黏膜段的体外生物黏附性和体内生物利用度,进一步研究 WGA 接枝脂质体作为口服递送脂溶性差的药物蟾毒灵的潜力。与不含 WGA 的脂质体相比,WGA 接枝脂质体与肠黏膜之间的黏附性显著增加(p<0.05)。通过给禁食大鼠口服 WGA 接枝脂质体和混悬液进行体内药效学研究。与混悬液相比,WGA 接枝脂质体显示出更大的 AUC 和 Cmax,口服生物利用度提高了 2.7 倍。这些结果表明,WGA 接枝脂质体作为口服递送蟾毒灵等脂溶性差的药物具有潜在的应用价值。